Submitted:
16 March 2020
Posted:
17 March 2020
You are already at the latest version
Preprints on COVID-19 and SARS-CoV-2
Abstract
There is a long trail of research studies testing the in vitro and in vivo efficacy of chloroquine and its derivatives in treating and preventing infection by various coronavirus species. More recent findings have highlighted the possibility of treating patients infected with the 2019 novel coronavirus, SARS-CoV-2. This review describes the mechanism of coronavirus infection, the mechanism of action of chloroquine, and summarizes the available literature highlighting the efficacy of chloroquine as an anti-coronavirus agent. These findings should encourage the wider scientific community to conduct thorough research on the possible efficacy of chloroquine and its derivatives in treating and preventing SARS-CoV-2 infection.
Keywords:
Antimalarial
; Chemoprophylaxis
; Chloroquine
; Coronavirus
; COVID-19
; Global Health
; Hydroxychloroquine
; Public Health
; SARS-CoV-2
; Virus
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.